USPTO serial 79173176
ACACIA PHARMA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 21, 2016
- Examiner
- PINO, BRIAN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with ACACIA PHARMA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*
Plus Government fees of $1,700
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Karl M. Zielaznicki, Esq.
Karl M. Zielaznicki, Esq. Troutman Pepper Hamilton Sanders LLP600 Peachtree Street, NE, Suite 3000c/o TM DKT CLKAtlanta, GA 30308-2216Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Sanitary preparations for medical purposes; pharmaceutical preparations for the management of post-operative nausea and vomiting (PONV); pharmaceutical preparations for the management of chemotherapy induced nausea and vomiting (CINV); pharmaceutical preparations for the management of xerostomia (dry mouth); pharmaceutical preparations for the management of cancer cachexia; pharmaceutical preparations for the management of cancer treatment side effects; pharmaceutical preparations for the management of side effects of surgery; pharmaceutical preparations for the management of cancer side effects; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations associated with surgery | ACTIVE | — |
| 042 | Scientific and technological services and research and design relating thereto, namely, scientific research, analysis and testing in the field of repurposing existing drugs for new therapeutic uses; pharmaceutical and veterinary product evaluation, development and testing services; pharmaceutical research, inspection and testing; medical and pharmaceutical research services; scientific research for medical purposes in the area of cancerous disease; pharmaceutical research, inspection, testing, development and evaluation of pharmaceutical and veterinary preparations, sanitary preparations for medical purposes, dietetic food and substances adapted for medical or veterinary use, pharmaceutical preparations for the management of post-operative nausea and vomiting (PONV), pharmaceutical preparations for the management of chemotherapy induced nausea and vomiting (CINV), pharmaceutical preparations for the management of xerostomia (dry mouth), pharmaceutical preparations for the management of cancer cachexia, pharmaceutical preparations for the management of cancer treatment side effects, pharmaceutical preparations for the management of side effects of surgery, pharmaceutical preparations for the management of cancer side effects, pharmaceutical preparations for the treatment of cancer, pharmaceutical preparations associated with surgery; information, advisory and consultancy services relating to the aforementioned services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Acacia Pharma Limited
- Other trademarks owned by Acacia Pharma Limited
- Other trademarks owned by Acacia Pharma Limited
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named ACACIA PHARMA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 31, 2024 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Oct 11, 2023 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Aug 25, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 4, 2023 | RHRD | RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED | — |
| Sep 3, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 5, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 5, 2022 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Aug 5, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 5, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 6, 2022 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Feb 18, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 21, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 12, 2022 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jan 12, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 12, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 12, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 12, 2022 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jul 30, 2020 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 11, 2016 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 20, 2016 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 20, 2016 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 21, 2016 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 21, 2016 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 5, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 16, 2016 | NPUB | NOTICE OF PUBLICATION | — |
| Mar 1, 2016 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Feb 23, 2016 | ALIE | ASSIGNED TO LIE | — |
| Feb 11, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 11, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 11, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 10, 2016 | ALIE | ASSIGNED TO LIE | — |
| Feb 5, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 24, 2015 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 8, 2015 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 8, 2015 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 8, 2015 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 7, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 6, 2015 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 2, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 2, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 1, 2015 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |